雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Personalized medicine in cardiovascular disease Shinpei Nonen 1 , Junichi Azuma 2 1Department of Biopharmaceutics, School of Pharmacy, Hyogo University of Health Sciences 2Department of Clinical Pharmacogenomics, School of Pharmacy, Hyogo University of Health Sciences Keyword: 先天性QT延長症候群 , 心不全 , 個別化医療 , 遺伝子変異 , 遺伝子多型 pp.1143-1149
Published Date 2010/10/15
DOI https://doi.org/10.11477/mf.1542102411
  • Abstract
  • Look Inside
  • Reference

Recently, important progress has been made in pharmacogenomic (PGx) study in cardiovascular disease. Congenital long QT syndrome (cLQTS) is treated according to its subtype of the syndrome. It is revealed that genetic information must be taken into consideration during cLQTS diagnosis and treatment. And bucindolol whose efficacy on heart failure cannot be demonstrated in mega clinical trial is revealed to exhibit the efficacy on heart failure in only patients with a certain genotype. Thus, application of bucindolol intended for genotype-guided heart failure therapy has been submitted to U.S. Food and Drug Administration (FDA). Further advances are expected in PGx study in cardiovascular disease.


Copyright © 2010, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1367 印刷版ISSN 0485-1420 医学書院

関連文献

もっと見る

文献を共有